MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$143,623K
Net Income
$97,584K
Net Profit Margin
67.94%
EPS
$1.58
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2025-06-30
2025-03-31
2024-12-31
2024-09-30
Collaboration revenue
143,623
499
1,131*
516
General and administrative
9,581
11,049
-5,878*
18,761
Research and development
5,863
22,337
22,428*
46,142
Impairment and disposal of long-lived assets
31,917
21,889
-
-
Total operating expenses
47,361
55,275
16,550*
64,903
Income (loss) from operations
96,262
-54,776
-15,419*
-64,387
Interest income
1,322
-
3,914
2,957
Total other income
1,322
-
3,914*
2,957
Loss before income tax expense
-
-
-11,505
-61,430
Net income (loss)
97,584
-
-11,505
-61,430
Basic EPS
1.59
-0.86
-0.191
-1.01
Diluted EPS
1.58
-0.86
-0.191
-1.01
Basic Average Shares
61,462,957
61,162,762
60,371,295
60,657,797
Diluted Average Shares
61,751,283
61,162,762
60,371,295
60,657,797
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Collaboration revenue
$143,623K
Interest income
$1,322K
Income (loss) from
operations
$96,262K
Total other income
$1,322K
Total operating
expenses
$47,361K
Net income (loss)
$97,584K
Impairment and disposal of
long-lived assets
$31,917K
General and
administrative
$9,581K
Research and development
$5,863K
Buy us a coffee
IGM Biosciences, Inc. (IGMS)
IGM Biosciences, Inc. (IGMS)